Summer Sale
50% off Premium Yearly
NASDAQ:IMMU
Immonumedics (IMMU)
Financials 
Technical Analysis Just four years, this traded at $2, and over $8 last April. It's had 3 CEOs in 18 months, but it was a viable cancer franchise that could be a huge business in a couple years. Gilead announced it was buying it today for $88. Immunomedics shot up nearly 98%.
- «
- ‹
- 1
- ›
- »
Immonumedics (IMMU) Frequently Asked Questions
What is Immonumedics stock symbol?
Immonumedics is a American stock, trading under the symbol IMMU (previously IMMU-Q on Stockchase) on the NASDAQ (IMMU). It is usually referred to as NASDAQ:IMMU or IMMU
Is Immonumedics a buy or a sell?
In the last year, no analyst issued a Buy, Sell, or Hold rating on IMMU (previously IMMU-Q on Stockchase) on Stockchase. Read the latest expert commentary for Immonumedics.
Is Immonumedics a good investment or a top pick?
Immonumedics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Immonumedics.
Why is Immonumedics stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Immonumedics.
Is Immonumedics worth watching?
Immonumedics is covered by Stockchase experts and is worth watching.
What is Immonumedics stock price?
On 2020-10-22, Immonumedics (IMMU) stock closed at a price of $87.85.
